COVID-19患者肾损伤患病率及其与危重症和死亡的关联
该回顾性研究纳入中国武汉和深圳两个队列共555例COVID-19患者,发现42%存在任何肾损伤,蛋白尿、血尿和AKI分别占33%、22%和6%。多因素Cox回归显示蛋白尿、血尿和院内AKI与死亡独立相关,且蛋白尿和血尿与进展为危重症相关。
要点
- COVID-19患者肾损伤常见,任何肾损伤达42%。
- 蛋白尿、血尿和院内AKI是死亡的独立危险因素。
- 蛋白尿和血尿与非危重症患者进展为危重症相关。
核心结论
- 肾损伤在COVID-19患者中常见,且与不良临床结局相关。
研究设计与样本
- 回顾性研究,纳入两个代表性队列:队列1为武汉的重型和危重型COVID-19患者,队列2为深圳全市COVID-19患者,共555例。
主要发现
- 42%(229/549)患者检出任何肾损伤,33%(174/520)检出蛋白尿,22%(112/520)检出血尿,6%(29/520)检出AKI。
- 随访结束时27例(5%)死亡;蛋白尿患者病死率11%(20/174),血尿患者16%(18/112),AKI患者41%(12/29)。
- 多因素Cox回归显示蛋白尿(HR 4.42,95%CI 1.22-15.94)、血尿(HR 4.71,95%CI 1.61-13.81)和院内AKI(HR 6.84,95%CI 2.42-19.31)与死亡相关。
- 在520例入院时非危重症患者中,蛋白尿(HR 2.61,95%CI 1.22-5.56)和血尿(HR 2.50,95%CI 1.23-5.08)与研究期间进展为危重症相关。
关键数值与推荐
- 任何肾损伤定义为血尿、蛋白尿、院内AKI或院前AKI任一存在。
- AKI按KDIGO肌酐标准定义。
临床怎么用
- 对COVID-19患者应监测蛋白尿、血尿和AKI,以识别死亡和进展为危重症的高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Coronavirus disease 2019 is spreading rapidly across the world. This study aimed to assess the characteristics of kidney injury and its association with disease progression and death of patients with coronavirus disease 2019. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This is a retrospective study. Two representative cohorts were included. Cohort 1 involved severe and critical patients with coronavirus disease 2019 from Wuhan, China. Cohort 2 was all patients with coronavirus disease 2019 in Shenzhen city (Guangdong province, China). Any kidney injury was defined as the presence of any of the following: hematuria, proteinuria, in-hospital AKI, or prehospital AKI. AKI was defined according to the Kidney Disease Improving Global Outcomes (KDIGO) creatinine criteria. The primary outcome was death at the end of follow-up. The secondary outcome was progression to critical illness during the study period. RESULTS: A total of 555 patients were enrolled; 42% of the cases (229 of 549) were detected with any kidney injury, 33% of the cases (174 of 520) were detected with proteinuria, 22% of the cases (112 of 520) were detected with hematuria, and 6% of the cases (29 of 520) were detected with AKI. Of the 29 patients with AKI, 21 cases were recognized as in-hospital AKI, and eight were recognized as prehospital AKI. Altogether, 27 (5%) patients died at the end of follow-up. The death rate was 11% (20 of 174) in patients with proteinuria, 16% (18 of 112) in patients with hematuria, and 41% (12 of 29) in the AKI settings. Multivariable Cox regression analysis showed that proteinuria (hazard ratio, 4.42; 95% confidence interval, 1.22 to 15.94), hematuria (hazard ratio, 4.71; 95% confidence interval, 1.61 to 13.81), and in-hospital AKI (hazard ratio, 6.84; 95% confidence interval, 2.42 to 19.31) were associated with death. Among the 520 patients with noncritical illness at admission, proteinuria (hazard ratio, 2.61; 95% confidence interval, 1.22 to 5.56) and hematuria (hazard ratio, 2.50; 95% confidence interval, 1.23 to 5.08) were found to be associated with progression to critical illness during the study period. CONCLUSIONS: Kidney injury is common in coronavirus disease 2019, and it is associated with poor clinical outcomes. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_09_18_CJN04780420.mp3.
引用
- Zheng X, Yang H, Li X, et al. Prevalence of Kidney Injury and Associations with Critical Illness and Death in Patients with COVID-19. Clin J Am Soc Nephrol. 2020. PMID: 32943396. doi:10.2215/CJN.04780420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。